Regional Organising Committee

Prof. Fadi Mirza Chair of Obstetrics, Gynecology, and Women’s Health Dubai Health

Dr. Mirza received his medical degree from the American University of Beirut (AUB) in Lebanon before he relocated to the United States for post-graduate training. He completed a four-year residency in Obstetrics and Gynecology at Tufts University in Boston. He then pursued a three-year fellowship in Maternal Fetal Medicine at Columbia University in New York. He subsequently became certified by the American Board of Obstetrics and Gynecology (ABOG)in both Obstetrics and Gynecology and Maternal Fetal Medicine. He is a fellow of the American College of Obstetricians and Gynecologists (ACOG). He also holds an Executive Masters in Business Administration (MBA) from Hult International Business School.

Upon completion of his post-graduate training, Dr. Mirza joined Columbia University as a full-time faculty, where he was active inpatient care, education, and research at its medical center in New York. He later returned to Beirut, where he joined the full-time faculty of AUB and its medical center (AUBMC), raising through the ranks to Associate Professor. He currently practices at the Latifa Hospital of Dubai Academic Health Corporation and is a Professor at the Mohammed Bin Rashid University (MBRU) as part of its clinical faculty.

At an academic level, Dr. Mirza was the Director of the AUB Obstetrics and Gynecology residency training program, a United States ACGME-I accreditedprogram, for three years. He was also a member of the Faculty of Medicine Admissions Committee and served on the thesis committee of a number of graduate students. Currently at Mohammed Bin RashidUniversity (MBRU), he serves as Associate Designated Institutional Officer (DIO) and Site Director of Latifa Hospital, overseeing the hospital’s residency and fellowship programs. He continues to supervise the research projects of a number of undergraduate, medical students, and residents.

At an administrative level, Dr. Mirza currently serves as the Chair of Obstetrics, Gynecology, and Women’s Health at Dubai Health, the first integrated academic healthcare system comprised of 6 hospitals and 27primary care centers. He also serves as the Medical Director (Chief Medical Officer) of Latifa Hospital, Dubai Health’s flagship women’s hospital. Of note, upon joining Latifa hospital in 2021, he was appointed as Director of Maternal Fetal Medicine, and, in 2022, he was appointed as Director of the Department of Obstetrics. In March 2024, he was appointed as the Chair of Obstetrics, Gynecology, and Women’s Health of Dubai Health.

Prior to his tenure at Dubai Health, Dr. Mirza previously held a number of senior positions at AUBMC; most notably, he served as the Founding Director of the Clinical Practice Improvement Program and as Co-Chairperson of its Patient Safety Council, working closely with the Joint Commission International (JCI). He was also the Chairperson of the hospital’s Credentialing and Privileging Committee and the Director of Medical Staff Affairs.

Dr. Mirza has presented many scientific abstracts and has published numerous peer-reviewed articles. Given his international recognition, he was invited to serve on a number of local, national, and international scientific committees, including the International Federation of Gynecology and Obstetrics (FIGO)’s intrapartum fetal monitoring consensus panel. In the United States, he served as an examiner for the Nuchal Translucency Quality Review (NTQR) and Cervical Length Education and Review (CLEAR) programs. In Lebanon, he served as an expert for the Maternal Mortality Committee of the Ministry of Public Health. In the UAE, he serves as the Chairperson of the Maternal Fetal Medicine Subcommittee of the National Institute for Health Specialties (NIHS). He also represents the UAE to the Scientific Committee of the Arab Board-Obstetrics and Gynecology. Additionally, he acts as the European Board of Obstetrics and Gynecology Examination Coordinator in Dubai.

He currently serves on the Board of Trustees of the Makassed Philanthropic Association for a second term. In the latter, he also serves as the Chairperson of the Board’s Health Committee that oversees a tertiary care medical center and a number of ambulatory centers. HE also sits on the UAE Leadership Board of Fight Cancer Global, based in the US. He has previously served for two terms as member of the managing board of the Lebanese Society of Obstetrics and Gynecology (LSOG) and as Chairman of its Scientific Committee. He has also served as the Co-Chairperson of the Scientific Committee of the Federation of Arab Gynecology and Obstetrics Societies (FAGOS), President of the Emirates Fetal Medicine Society(EFMS), and Vice President of the Lebanese Joint Coalition Against Thrombosis (LJCAT).

Dr. Mirza has been an invited speaker, Course Director, and Congress Chairperson at countless national, regional, and international conferences held in different parts of the world, including Bahrain, China, Egypt, France, Iraq, Italy, India, Jordan, Kenya, Kingdom of Saudi Arabia, Kuwait, Morocco, Oman, Poland, Portugal, Qatar, Russia, Switzerland, Tunisia, Turkey, United Arab Emirates, and Vietnam. He also serves on a number of advisory boards regionally and internationally. Dr. Mirza is the recipient of many significant awards. Most notably, he was decorated with the National Order of Merit Medal of the Lebanese Government. He is also the recipient of the Berlex Best Teaching Award and the Award of Research Excellence of the Society for Maternal Fetal Medicine in the US. He was an invitee to the National Institutes of Health (NIH)’s “Preparing for a Research Career in Perinatology and Reproductive Medicine” course in the US. Finally, he served on the prestigious Awards Committee of the International Hospital Federation (IHF) and on the Scientific Committee of its World Congress.

Country: UAE

Field: Obstetrics and Gynecology; Maternal Fetal Medicine

Specialties: High Risk Pregnancy; Fetal medicine; Prenatal Ultrasound

Languages: English; Arabic; French

Prof. Muna Tahlak Chief Medical Officer (CMO) and Vice Provost at Dubai Health

Prof. Muna Tahlak is the Chief Medical Officer (CMO) and Vice Provost at Dubai Health. Prof Tahlak is currently the Chief Executive officer (CEO) of Latifa Women and Children Hospital. She is also Adjunct Faculty at Mohamed Bin Rashid University, Dubai, UAE.

Prof. Tahlak is the first Arab Women to hold the position of President for the International Hospital Federation. She was the Regional Trustee for the Africa & Eastern Mediterranean Region for the International Federation of Obstetrics & Gynaecology for the period 2021- 2023. Also, she is the past President of Emirates Obstetrics and gynaecology society. Prof. Tahlak is an obstetrics and gynaecology consultant and the first Emirati lady to complete her specialization in obstetrics and gynaecology from the John Hopkins Hospital, United States of America (USA).

In 1997, she graduated from the Royal College of Surgeons of Ireland and topped her class in pathology. She is American Board Certified in Obstetrics and Gynecology and a fellow of the American Congress of Obstetrics and Gynecology since 2005. She completed Executive Master of Public Administration Program from Mohamed Bin Rashid School of Government in 2020. Prior to joining the Dubai Health Authority (DHA), Prof Tahlak worked in USA as an obstetrics and gynaecology consultant from 2004 to 2006. Prof. Muna joined Latifa Women and Children Hospital, Dubai Health Authority on 15 November 2006 as a Consultant Obstetrician/ Gynecologist. She later held the posts of Assistant Head of Obs/Gyn and Head of Obs/Gyn at Latifa Hospital. During her tenure as the head of the department, Prof. Tahlak developed the minimal invasive surgery services at the hospital. She established the outpatient office hysteroscopy procedure at the hospital without the need for hospitalization or anaesthesia as it used to be done previously. She also served as the Director of Obs/Gyn Residency Program of DHA from 2007 till 2010.

She is a member of several esteemed national and international societies and associations which includes:

▪ Member of American Congress of obstetricians and gynaecologists

▪ Member of American Association of Gynaecologic Laparoscopists.

▪ Fellow of International Academy of Human Reproduction (IAHR) Prof Tahlak regularly participates in various conferences as a speaker, she has received various awards for excellence in her field and she provides training for resident doctors. Prof Muna has many publications in peer reviewed journals.

Dr Imad Farid Aboujaoude (Lebanon) Medical and Scientific Director of Aboujaoude Hospital

Dr Aboujaoude is a Lebanese–French obstetrician-gynecologist and reproductive medicine specialist, trained at the Pitié-Salpêtrière School of Medicine in Paris, where he obtained his French Board (DES) and medical doctorate. He has been based in Lebanon since 1995 as the founder and director of the Center for Reproductive Medicine and Genetics (CRMG) at Aboujaoude Hospital, achieving the first Lebanese ICSI pregnancy that year and developing one of the country’s earliest cytogenetics and PGD programs.

A pioneer in ultrasound education in the region, Dr Aboujaoude has organized more than 20 ultrasound workshops, including multiple ISUOG Basic Training courses (2018–2020). He is an active member of ISUOG since 2007 and serves as President of the Lebanese Society of Perinatology. He has authored numerous presentations in international meetings (ISUOG, MEFS, ASRM, ESHRE) and has contributed to advancing early pregnancy imaging, fetal therapy, endometriosis, and infertility diagnostics.

Dr Aboujaoude is the Medical and Scientific Director of Aboujaoude Hospital, a board member of the Lebanese OB-GYN Society, and has trained generations of residents from the Lebanese University and Saint Joseph University. For 30 years, he has also led weekly national scientific meetings (“Jeudi Médical”), contributing significantly to medical education in Lebanon.

Dr. Shamsa Al-Awar (UAE) Associate Professor and Chair, Department of Obstetrics & Gynecology College of Medicine & Health Sciences, United Arab Emirates University

Dr. Shamsa Al-Awar is a distinguished Emirati physician, academic leader, and women’s-health advocate with over three decades of contributions to clinical excellence, medical education, and national health policy in the UAE. Board-certified by the American Board of Obstetrics & Gynecology and a Fellow of the Royal College of Physicians and Surgeons of Canada, she also holds the Fellowships of the American College of Obstetricians and Gynecologists (FACOG) and the American Board Academy (FABC).

Dr. Al-Awar is additionally certified by the American Board in Medical Quality (CMQ) and as a Medical Professional Legal Consultant (MPLC), reflecting her unique integration of clinical, quality-governance, and medicolegal expertise. She serves as Chair of the Department of Obstetrics and Gynecology at the College of Medicine & Health Sciences, UAE University, where she has led transformative innovations in undergraduate and postgraduate medical education aligned with ACGME-I standards.

Renowned for advancing women’s health and maternal safety, she has played a central role in establishing UAE national programs on perinatal surveillance (MPDSR), breast and cervical cancer prevention, and women’s well-being. A prolific scholar and frequent keynote speaker across the MENA region, Dr. Al-Awar has authored numerous peer-reviewed publications and policy papers on reproductive health, medical liability, and education reform. She is a recipient of multiple national awards honouring her leadership, innovation, and community service.

Dr. Al-Awar embodies the synergy of clinical mastery, academic innovation, and policy leadership serving as a role model for excellence and empowerment in women’s health across the Arab world. Dr. Al-Awar exemplifies the fusion of clinical expertise, educational innovation, and visionary leadership continuing to inspire the next generation of physicians and to champion the advancement of women’s health and wellbeing across the Arab world.

Dr Eman Alsulmi (UAE) MBBS, FRCSC, MSHA

Assistant Professor at the Imam Abdulrahman Bin Faisal University. Consultant Maternal Fetal Medicine in the Department of Obstetric and Gynecology at the King Fahad Hospital of the University.

Dr. Eman Alsulmi is a Consultant in Maternal–Fetal Medicine at King Fahad Hospital of the University and an Assistant Professor at Imam Abdulrahman Bin Faisal University in Saudi Arabia. She is the Director of the Translational Medical Research Center and leads the Clinical Trials Unit, overseeing early-phase and investigatorinitiated trials that support national research priorities. She completed her residency and Maternal–Fetal Medicine fellowship at the University of Manitoba in Canada, followed by an Executive Master of Science in Health Administration from the University of Alabama at Birmingham. She also holds advanced clinical research training from Harvard Medical School. Dr. Alsulmi is President of the Saudi Society of Maternal-Fetal Medicine and contributes to shaping national standards in women’s health, ultrasound practice, and research governance. Recognized for her leadership in advancing maternal–fetal innovation and capacity-building, she collaborates widely with international partners to elevate clinical practice and ultrasound excellence across the region.

Dr Liat Gindes (Israel) Director of the Ob/Gyn Ultrasound Division at Wolfson Medical Center

Prof. Liat Gindes is a professor of Obstetrics and Gynecology at Tel-Aviv University. Her area of expertise is fetal ultrasound imaging. Dr. Gindes is the Ultrasound division director at the Department of Obstetrics and Gynecology, and a co-director of the multidisciplinary fetal neurology clinic at Wolfson Medical Center, Holon, Israel (2014 – present). She has previously held leadership roles: the chair of the 3D Special Interest Group of ISUOG and chair of the Fetal Echocardiography Community of the AIUM. She is an honorary fellow of the AIUM for outstanding contributions to the field of medical ultrasound.

Notable Publications: https://pubmed.ncbi.nlm.nih.gov/?term=Gindes%20L&sort=date

Country: Israel

Field: Gynecology/Obstetrics

Specialties: Fetal anomalies screening and consultation; fetal echocardiography; first trimester fetal echocardiography; Neurosonography; 3D & 4D ultrasound; fetal blood vessels, facial anomalies

Languages: English; Hebrew

Languages: English; Hebrew

Dr. Mauricio Herrera (UAE) Chief Medical Officer and Head of the Maternal-Fetal Medicine Department at Burjeel Hospital and Burjeel Medical City

Dr. Mauricio Herrera is a highly regarded Consultant Specialist Obstetrician Gynecologist with expertise in Maternal-Fetal Medicine, Fetal Surgery and Therapy, Fetal Cardiology, and Fetal Neurology. With decades of experience, he is recognized globally as a leading expert in maternal-fetal health and advanced surgical interventions. At Burjeel Hospital and Burjeel Medical City, Dr. Herrera serves as the Chief Medical Officer and Head of the Maternal-Fetal Medicine Department. In this role, he leads initiatives in maternalfetal medicine, concentrating on complex cases, congenital anomalies, and innovative diagnostic techniques. Additionally, Dr. Herrera has held the position of Director and Head of the Maternal-Fetal Department at Colsanitas Clinic – Keralty Holdings since 2001. Dr. Herrera serves as the director of the International Center for Fetal Surgery and Therapy, which is a referral center for validated fetal surgeries and therapies. Each year, he oversees more than 130 cases involving patients from various regions in Colombia, as well as from other countries in Latin America. Additionally, he holds the position of President of the Maternal-Fetal Medicine Foundation. He dedicates all the time for the Maternal Fetal Medicine, Prenatal Diagnosis and Fetal therapy and surgery

Prof. Mohamed Kamal Etman (Egypt) ISUOG Ambassador to Middle East and North Africa

Prof. Mohamed Kamal Etman trained in Obstetrics and Gynecology at Ain Shams University, where he later subspecialized in Fetal Medicine. He currently serves as a Full Professor of Obstetrics, Gynecology, and Fetal Medicine at the Faculty of Medicine, Fayoum University, Egypt, and as a Consultant in Fetal Medicine and High-Risk Obstetric Care. Previously, he was a Consultant in the Maternal-Fetal Medicine Unit at Ain Shams University Hospital, where he was actively involved in the implementation of evidence-based clinical guidelines.

Prof. Etman is the Founder and President of the Egyptian Fetal Medicine Foundation (EFMF) and the Director of the ISUOG Outreach Program in Egypt. He also obtained his medical degree and completed his residency training at Ain Shams University. Additionally, he was a Visiting Fellow in Obstetrics and Gynecology Ultrasound and Fetal Echocardiography in the Department of Radiology at Sidney Kimmel Medical College, Thomas Jefferson University, Pennsylvania, USA.

Since 2017, Prof. Etman has organized and led numerous ISUOG-endorsed Fetal Medicine and Obstetrics Ultrasound workshops, training hundreds of healthcare practitioners across Egypt and the broader Middle East and North Africa (MENA) region. He has also conducted ISUOG Basic Training courses in Sudan, Libya, and several other MENA countries, contributing to the advancement of ultrasound education and capacity building in the region.

As an active ISUOG Ambassador to the MENA region, Prof. Etman has delivered multiple ISUOG-approved courses, encouraging hundreds of physicians to join and engage with ISUOG. He was also the Organizer and Chair of ISUOG’s 16th International Symposium held in Cairo, Egypt.

Country: Egypt

Field: Obstetrics, Gynecology, Fetal Medicine

Specialties: Fetal anomaly screening first and second trimester, fetal biometry and wellbeing, fetal anomalies screening, aneuploidy screening, fetal anomalies, fetal heart, fetal growth restriction, maternal and fetal doppler, multiple pregnancy, 3D/4D ultrasound, gynecological ultrasound, early pregnancy, preterm delivery; fetal growth; detection of fetal and neonatal growth abnormalities

Languages: Arabic, English

Publications / Research Work

Etman, M.K.K., El-Baradie, S.M.Y., Badran, H.M.A., & Elsayed, R.H.E., Fetal thymus volume as a marker for intrauterine growth restriction. Fayoum University Medical Journal, Vol. 15, Issue 1, 2025.
Etman, M.K.K., et al. Fetal adrenal gland volume in normal versus growth-restricted fetuses.
Fayoum University Medical Journal, Vol. 15, Issue 1, 2025.
Etman, M.K., Sofy, M.S., & Abd El-Mneim, A.E.A. Post COVID-19 effect on ovarian reserve in women of reproductive age: An analytical before-and-after COVID-19 study.Egyptian Journal of Fertility and Sterility, Vol. 27, Issue 5, 2023.
Ayoub, S.E., Shaker, O.G., Aboshama, R.A., Etman, M.K., Khalefa, A.A., Zaki, O.M., Ali, D.Y., Hemeda, N.F., Amin, A., & Ali, M.A. Expression profile of LncRNA ANRIL, miR-186, miR-181a, and MTMR-3 in patients with preeclampsia.Non-coding RNA Research, 2023.
Etman, M.K., Youssef, V.A., Bakry, M.S., & El-Baradie, S.M.Y. Uterocervical angle and cervical length as predictors for preterm birth in low-risk women. Egyptian Journal of Fertility and Sterility, 2023.
Etman, M.K., Abd El-Hafeez, G.M., Bakry, M.S., & El-Baradie, S.M.Y. Role of uterocervical angle, cervical length, and cervicovaginal fetal fibronectin in the prediction of preterm birth. International Journal of Childbirth, 2023.
Metwally, A.A.Z., Ismail, M.T., Hassanin, M.S.E., & Etman, M.K. Accuracy of fetal structural anomalies detection by ultrasonography at 14–16 weeks of gestation in Fayoum University Hospital: Upper Egypt experience. Ultrasound in Obstetrics & Gynecology, Vol. 60 (S1), 2022.
Youssef, A.A.Z., Ismail, M.T., Hassanin, M.S.E., & Etman, M.K. Two-dimensional ultrasonography at 14–16 weeks of gestation for detection of fetal structural anomalies. Egyptian Journal of Fertility and Sterility, Vol. 26, Issue 2, 2022.
Abdelfattah, L.E., Aboshama, R.A., Abdelsamie, A.A., Etman, M.K., & Abdelghany, A.A. Evaluation of gestational sac diameter, crown-rump length, yolk sac diameter, and fetal heart rate in early detection of congenital fetal malformation. Egyptian Journal of Fertility and Sterility, 2022.
Abd El-Mneim, A.A., Yehya, S.M., & Etman, M.K. Uterine niche and secondary infertility: Agreement in diagnosis using hysterosalpingography vs. hydrosonography. Evidence-Based Women’s Health Journal, 2022.
Hashad, A.M.N., Elkholy, H.A.K., Etman, M.K., & Ibrahim, I.M. Assessment of hysteroscopic role in management of women with recurrent pregnancy loss. Egyptian Journal of Hospital Medicine, Vol. 72, Issue 6, 2018.
Rabei, N.H., El-Helaly, A.M., Farag, A.H., El-Naggar, A.K., Etman, M.K., & El-Moteily, M.M. A study of endometrial perfusion in unexplained infertility. International Journal of Gynecology & Obstetrics, Vol. 137, Issue 1, 2018.
Laban, M., Alanwar, A.A., Etman, M.K., Elsokkary, M.S., Elkotb, A.M., Hasanien, A.S., KhalafAllah, A.E., & Noah, N.M. Five-dimensional long bones biometry for estimation of femur length and fetal weight at term compared to two-dimensional ultrasound: A pilot study. Journal of Maternal-Fetal & Neonatal Medicine, Vol. 31, Issue 11, 2018.
Laban, M., Hussain, S.H., Hassanin, A.S., Khalaf, W.M., Etman, M.K., Elsafty, M.S.E., Bahaa Eldin, A.M., Hasanien, A.S., Sakna, N.A., Taema, M., Mostafa, M.H., & Eisa, M.M. Endometrial volume measured by VOCAL compared to office hysteroscopy for diagnosis of endometrial polyps in premenopausal women with abnormal uterine bleeding. Obstetrics and Gynecology International, Article ID 3561324, 2016.

WhatsApp Image 2025-08-04 at 08.16.50.jpeg

Muna Khalfan (UAE) Chief Medical Officer at Al Reaya Al Raqeyah Specialist Medical Center, Sharjah

Dr Muna Khalfan Is the Chief Medical Officer; consultant Obstetrician; Gynecologist & Fetal Medicine; Al Reaya Al Raqeyah Specialist Medical Center; Sharjah; UAE from 18^th November up to date.

Head of Obstetrics ; Gynecology &Fetal Medicine in Al Qassimi Women and Children Hospital &Head of Termination Committee in Ministry of Health &Prevention ( MOHAP) and Chief examiner in MOHAP from 2015 up to 5/8/2025.

Graduated from King Saud University 1990 & had Arab Board in Obstetrics & Gynecology in 2000. Had Master of Ultrasound in Obstetrics and Gynaecology, 17 June 2008, from University of Zagreb medical school, Republic of Croatia & specialized post graduate training in advanced ultra sound in obstetrics and gynecology, March 12th 2008, Ian Donald inter-university school of medical ultra sound, Doha branch, Qatar. She is a adjunct Professor in Sharjah medical University and faculty in Postgraduate Diploma in Ultrasound Technology Applications. AlSO Instructor & CTG Instructor in EHS.

Prof. Hisham Mirghani (UAE) Consultant & Chair of Fetal Medicine Services at NMC Hospitals

Prof. Hisham Mirghani:

Education

Master's Degree in Health Professions Education (MHPE), University of Maastricht, The Netherlands, June 2012.
Fellow of the Royal College of Obstetricians & Gynecologists (FRCOG), London, UK, 2007.
Maternal Fetal Medicine Fellowship, University of Toronto, Canada, 1997–1999.
Advanced Obstetrical Ultrasound, RCOG/RCR, London, UK, 1995–1996.
MRCOG, London, United Kingdom, May 26, 1995.

Positions

Consultant & Chair of Fetal Medicine Services at NMC Hospitals, February 2023 – present.
Consultant & Chair, Fetal Medicine Department, Danat AL Emarat Hospital,
Abu Dhabi. Nov. 2017 – Feb. 2023.
Head of Academic Affairs , Danat AL Emarat Hospital, Abu Dhabi. Nov. 2017 – Feb. 2023.
Professor of the Department of Obstetrics & Gynecology. United Arab
Emirates University from August 2001 to 2015.
Chair of Department of Obstetrics & Gynecology 2007 - 2014.

ISUOG Service

Member of ISUOG International Faculty.
Previous member of ISUOG Advisory Group
Previous Chair of ISUOG Outreach Committee
Previous ISUOG Ambassador to UAE & Middle East

Notable publications:

Begam MA, Alsafi W, Bekdache GN, Chedid F, Al-Gazali L, Mirghani HM. Stuve-Wiedemann syndrome: a skeletal dysplasia characterized by bowed long bones. Ultrasound in Obstetrics & Gynecology. 2011;38(5):553-8.

Mirghani H, Begam M, Bekdache G, Khan F. Specialised fetal and maternal service: outcome of pre-gestational diabetes. Journal of Obstetrics and Gynaecology. 2012;32(5):426-9.

Country: United Arab Emirates

Field: Obstetrics

Specialties: Fetal anomaly screening 1st trimester and 2nd trimester; fetal biometry; fetal anomalies screening; aneuploidy screening; fetal anomalies; fetal heart; fetal growth restrictions; maternal and fetal Doppler; multiple pregnancy; early pregnancy; detection of fetal and neonatal growth abnormalities.

Languages: English; Arabic

Dr Prathima Radhakrishnan (India) ISUOG Ambassador to India (2021–2026)

Specialties: Fetal Therapy, Aneuploidy Screening, Multi-fetal Pregnancy, and AI-driven Imaging.

Dr. Prathima Radhakrishnan is a distinguished leader in fetal medicine, serving as the ISUOG Ambassador to India for the 2021–2026 term. As the first Indian to receive a Diploma in Fetal Medicine from the Fetal Medicine Foundation (FMF-UK), she has bridged the gap between international diagnostic standards and Indian clinical practice for over two decades.

Global Advocacy & Leadership

In her capacity as an ISUOG Ambassador, Dr. Radhakrishnan acts as a vital link between the global society and the Indian medical community. Her leadership focuses on:

Standardizing Education: Promoting ISUOG’s clinical guidelines to ensure uniform quality in obstetric ultrasound across the Indian subcontinent.
Scientific Contribution: A frequent faculty member and moderator at ISUOG and other World Congresses, she has delivered talks on various topics related to fetal imaging and therapy
AI Integration: Advancing the society’s mission to reduce operator dependence in ultrasound through research into Deep Learning and automated biometric segmentation. The integration of AI in first trimester imaging and FMF audit process has received widespread acclaim for Dr Prathima.

Clinical & Academic Excellence

Beyond her advocacy, Dr. Radhakrishnan is the Director of the Bangalore Fetal Medicine Centre (BFMC), a premier tertiary referral and training hub. Her technical contributions to the field include:

Pioneering Fetal Therapy: The first in India to perform therapeutic fetoscopic laser surgery for complex monochorionic twin pregnancies.
Prolific Research: Over 50 peer-reviewed publications and book chapters, focusing on screening for pre-eclampsia, fetal growth restriction, multiple pregnancies and aneuploidies.
Global Training: As an FMF-accredited trainer, she has mentored thousands of specialists globally through innovative online and on-site ultrasound programs.

Public-Private Parity and Social Impact

With her latest ventures, Dr. Radhakrishnan has democratized high-end fetal care through groundbreaking Public-Private Partnerships (PPP). Her units—Ajaatha (Unit of IGICH) and Agama Fetal Medicine Centres—provide the underprivileged with access to advanced fetal therapies and diagnostics, ensuring that economic status does not dictate the survival of the fetus.

Global Advocacy and Vision

Dr. Radhakrishnan is dedicated to the democratization of fetal care. Her work in Public-Private Partnerships ensures that ISUOG’s "best practice" standards reach underprivileged populations, ensuring that advanced diagnostics and lifesaving in-utero therapies are available to all, regardless of economic status.

Currently serving as the ISUOG Ambassador for India (2021–2026), she is a leading voice on the future of the specialty. Her vision includes:

AI Integration: Utilizing Artificial Intelligence to standardize fetal imaging and reduce inter-observer variability.
Curriculum Reform: Incorporating fetal medicine into medical education to recognize the fetus as a distinct patient.
Paternal Involvement: Advocating for partner participation to improve maternal mental health and neonatal outcomes.

Beyond the clinic, Dr. Radhakrishnan is a trained Bharatanatyam dancer and the recipient of the DSV Mrs. Grand Medico Diva 2024 title. She embodies a rare blend of clinical rigor, academic excellence, and cultural grace.

Dr. Amel Ibrahim Almaeeni Senior Consultant in Obstetrics and Gynecology at the Chief Medical Officer of Fujairah Hospital under Emirates Health Services

Dr. Amel Ibrahim Almaeeni is a Senior Consultant in Obstetrics and Gynecology and currently serves as the Chief Medical Officer of Fujairah Hospital under Emirates Health Services (EHS) in the United Arab Emirates. She also chairs the Central OBGYN Committee across EHS, where she leads system-wide initiatives to enhance the quality, safety, and standards of maternity and women’s health services.

Her clinical background includes advanced training in Maternal–Fetal Medicine, Obstetric Ultrasound, Genetic Counseling, and Leadership and Strategic Management. She is actively involved in national programs focused on improving maternal outcomes, strengthening MPDSR processes, developing clinical guidelines, and expanding fetal medicine capabilities across the UAE.

In addition to her clinical and leadership roles, she is an Associate Professor at RAK Medical & Health Sciences University, contributing to academic teaching, research, and capacity-building for the next generation of OBGYN specialists.

Regional Organising Committee